GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » EV-to-FCF

BLIS Technologies (NZSE:BLT) EV-to-FCF : 27.86 (As of May. 28, 2024)


View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BLIS Technologies's Enterprise Value is NZ$13.54 Mil. BLIS Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.49 Mil. Therefore, BLIS Technologies's EV-to-FCF for today is 27.86.

The historical rank and industry rank for BLIS Technologies's EV-to-FCF or its related term are showing as below:

NZSE:BLT' s EV-to-FCF Range Over the Past 10 Years
Min: -607.44   Med: -18.87   Max: 3245.81
Current: -22.49

During the past 13 years, the highest EV-to-FCF of BLIS Technologies was 3245.81. The lowest was -607.44. And the median was -18.87.

NZSE:BLT's EV-to-FCF is ranked worse than
100% of 369 companies
in the Biotechnology industry
Industry Median: 8.9 vs NZSE:BLT: -22.49

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), BLIS Technologies's stock price is NZ$0.017. BLIS Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.001. Therefore, BLIS Technologies's PE Ratio for today is 17.00.


BLIS Technologies EV-to-FCF Historical Data

The historical data trend for BLIS Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies EV-to-FCF Chart

BLIS Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.01 -75.18 -17.29 3,245.80 35.54

BLIS Technologies Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.29 - 3,245.80 - -

Competitive Comparison of BLIS Technologies's EV-to-FCF

For the Biotechnology subindustry, BLIS Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BLIS Technologies's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's EV-to-FCF falls into.



BLIS Technologies EV-to-FCF Calculation

BLIS Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=13.540/0.486
=27.86

BLIS Technologies's current Enterprise Value is NZ$13.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BLIS Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BLIS Technologies  (NZSE:BLT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

BLIS Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.017/0.001
=17.00

BLIS Technologies's share price for today is NZ$0.017.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BLIS Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


BLIS Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


BLIS Technologies (NZSE:BLT) Business Description

Traded in Other Exchanges
N/A
Address
442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).

BLIS Technologies (NZSE:BLT) Headlines

From GuruFocus

John Rogers Trims Stake in Blount International

By Kyle Ferguson Kyle Ferguson 04-18-2016

Bill Nygren's Oakmark Comments on Blount International

By Holly LaFon Holly LaFon 07-10-2012

Olstein Strategic Opportunities Fund 2014 Investor Letter

By Canadian Value Canadian Value 04-01-2015

Ariel Fund Quarterly Commentary From John Rogers

By Holly LaFon Holly LaFon 01-21-2016

John Rogers Increases Stake in Blount International

By Tiziano Frateschi Tiziano Frateschi 04-13-2015